278 related articles for article (PubMed ID: 25086655)
1. Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models.
Martínez-Sánchez P; Gutiérrez-Fernández M; Fuentes B; Masjuán J; Cases MA; Novillo-López ME; Díez-Tejedor E;
J Transl Med; 2014 Aug; 12():220. PubMed ID: 25086655
[TBL] [Abstract][Full Text] [Related]
2. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
3. Fumarate decreases edema volume and improves functional outcome after experimental stroke.
Clausen BH; Lundberg L; Yli-Karjanmaa M; Martin NA; Svensson M; Alfsen MZ; Flæng SB; Lyngsø K; Boza-Serrano A; Nielsen HH; Hansen PB; Finsen B; Deierborg T; Illes Z; Lambertsen KL
Exp Neurol; 2017 Sep; 295():144-154. PubMed ID: 28602832
[TBL] [Abstract][Full Text] [Related]
4. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
[TBL] [Abstract][Full Text] [Related]
5. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.
Smith CJ; Emsley HC; Gavin CM; Georgiou RF; Vail A; Barberan EM; del Zoppo GJ; Hallenbeck JM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
BMC Neurol; 2004 Jan; 4():2. PubMed ID: 14725719
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site.
Tuttolomondo A; Di Sciacca R; Di Raimondo D; Serio A; D'Aguanno G; La Placa S; Pecoraro R; Arnao V; Marino L; Monaco S; Natalè E; Licata G; Pinto A
J Neuroimmunol; 2009 Oct; 215(1-2):84-9. PubMed ID: 19695716
[TBL] [Abstract][Full Text] [Related]
7. Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia.
Zhu XC; Jiang T; Zhang QQ; Cao L; Tan MS; Wang HF; Ding ZZ; Tan L; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):375-85. PubMed ID: 25172433
[TBL] [Abstract][Full Text] [Related]
8. 6-Mercaptopurine exerts an immunomodulatory and neuroprotective effect on permanent focal cerebral occlusion in rats.
Chang CZ; Kwan AL; Howng SL
Acta Neurochir (Wien); 2010 Aug; 152(8):1383-90; discussion 1390. PubMed ID: 20464434
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.
Kim HJ; Rowe M; Ren M; Hong JS; Chen PS; Chuang DM
J Pharmacol Exp Ther; 2007 Jun; 321(3):892-901. PubMed ID: 17371805
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients.
Bogoslovsky T; Spatz M; Chaudhry A; Maric D; Luby M; Frank J; Warach S
J Transl Med; 2011 Aug; 9():145. PubMed ID: 21871109
[TBL] [Abstract][Full Text] [Related]
11. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.
Petzold A; Michel P; Stock M; Schluep M
J Stroke Cerebrovasc Dis; 2008; 17(4):196-203. PubMed ID: 18589339
[TBL] [Abstract][Full Text] [Related]
12. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.
Licata G; Tuttolomondo A; Di Raimondo D; Corrao S; Di Sciacca R; Pinto A
Thromb Haemost; 2009 May; 101(5):929-37. PubMed ID: 19404547
[TBL] [Abstract][Full Text] [Related]
13. Infarct pattern and clinical outcome in acute ischemic stroke following middle cerebral artery occlusion.
Lee KJ; Jung KH; Byun JI; Kim JM; Roh JK
Cerebrovasc Dis; 2014; 38(1):31-8. PubMed ID: 25196965
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome.
Basic Kes V; Simundic AM; Nikolac N; Topic E; Demarin V
Clin Biochem; 2008 Nov; 41(16-17):1330-4. PubMed ID: 18801351
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokines and early neurological worsening in ischemic stroke.
Vila N; Castillo J; Dávalos A; Chamorro A
Stroke; 2000 Oct; 31(10):2325-9. PubMed ID: 11022058
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.
Emsley HC; Smith CJ; Gavin CM; Georgiou RF; Vail A; Barberan EM; Illingworth K; Scarth S; Wickramasinghe V; Hoadley ME; Rothwell NJ; Tyrrell PJ; Hopkins SJ
BMC Neurol; 2007 Feb; 7():5. PubMed ID: 17328808
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke.
Leira R; Rodríguez-Yáñez M; Castellanos M; Blanco M; Nombela F; Sobrino T; Lizasoain I; Dávalos A; Castillo J
J Intern Med; 2006 Oct; 260(4):343-9. PubMed ID: 16961671
[TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes.
Lehmann MF; Kallaur AP; Oliveira SR; Alfieri DF; Delongui F; de Sousa Parreira J; de Araújo MC; Rossato C; de Almeida JT; Pelegrino LM; Bragato EF; Lehmann AL; Morimoto HK; Lozovoy MA; Simão AN; Kaimen-Maciel DR; Reiche EM
Metab Brain Dis; 2015 Dec; 30(6):1417-28. PubMed ID: 26359121
[TBL] [Abstract][Full Text] [Related]
20. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases.
Ishrat T; Sayeed I; Atif F; Hua F; Stein DG
Exp Neurol; 2010 Nov; 226(1):183-90. PubMed ID: 20816826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
